David Arkowitz, CFO and Chief Business Officer at AMAG PHARMACEUTICALS INC. (AMAG), bought 172 shares at $31.78 ($5K) on 2009-12-01, disclosed to the SEC on 2009-12-02.
Open-market purchase of $5k AMAG by CFO and Chief Business Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| MCRB | SELL | 2023-10-31 | $5K | — | Filing → |
| FLXN | SELL | 2021-05-12 | $16K | — | Filing → |
| FLXN | SELL | 2021-01-07 | $135K | — | Filing → |